Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.2 EUR | +3.90% | +6.19% | -8.40% |
Mar. 29 | Laboratorio Farmaceutico Erfo, revenues grow and profit remains stable | AN |
Feb. 19 | Mib in the red at 31,600; TIM still on top | AN |
Sales 2023 * | 6.3M 6.82M | Sales 2024 * | 6.5M 7.03M | Capitalization | 10.4M 11.24M |
---|---|---|---|---|---|
Net income 2023 * | - 0 | Net income 2024 * | - 0 | EV / Sales 2023 * | 1.4 x |
Net cash position 2023 * | 1.6M 1.73M | Net cash position 2024 * | 2M 2.16M | EV / Sales 2024 * | 1.29 x |
P/E ratio 2023 * |
12.8
x | P/E ratio 2024 * |
19.3
x | Employees | 29 |
Yield 2023 * |
-
| Yield 2024 * |
-
| Free-Float | 22.6% |
1 day | +3.90% | ||
1 week | +6.19% | ||
Current month | +7.14% | ||
1 month | +5.73% | ||
3 months | +20.00% | ||
6 months | +22.45% | ||
Current year | -8.40% |
Managers | Title | Age | Since |
---|---|---|---|
Flavio Corpina
CEO | Chief Executive Officer | 45 | 16-12-31 |
Alessandro Cutè
CEO | Chief Executive Officer | 53 | 12-12-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Alessandro Cutè
CEO | Chief Executive Officer | 53 | 12-12-31 |
Flavio Corpina
CEO | Chief Executive Officer | 45 | 16-12-31 |
Fabio Giuffre
BRD | Director/Board Member | 43 | - |
Date | Price | Change | Volume |
---|---|---|---|
24-05-14 | 1.2 | +3.90% | 57 000 |
24-05-13 | 1.155 | +1.32% | 16,000 |
24-05-10 | 1.14 | 0.00% | 16,000 |
24-05-09 | 1.14 | +1.33% | 8,000 |
24-05-08 | 1.125 | -0.44% | 7,000 |
Real-time Borsa Italiana, May 14, 2024 at 11:44 am EDT
More quotesEPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-8.40% | 11.22M | |
+29.75% | 682B | |
+30.35% | 586B | |
-3.74% | 364B | |
+17.51% | 327B | |
+3.52% | 285B | |
+15.53% | 240B | |
+10.16% | 209B | |
-8.14% | 203B | |
+7.29% | 165B |
- Stock Market
- Equities
- ERFO Stock